Sven Thormahlen
Plus aucun poste en cours
Historique de carrière de Sven Thormahlen
Anciens postes connus de Sven Thormahlen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MucoVax GmbH | Directeur Général | - | - |
| CORBION N.V. | Directeur Technique/Scientifique/R&D | 12/05/2014 | - |
| L'ORÉAL | Directeur Technique/Scientifique/R&D | - | - |
| Corporate Officer/Principal | - | - | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Directeur/Membre du Conseil | 03/01/2012 | - |
| YAKULT HONSHA CO.,LTD. | Directeur/Membre du Conseil | 12/01/2010 | - |
| DANONE | Directeur Technique/Scientifique/R&D | 06/01/2010 | - |
Formation de Sven Thormahlen
| University of Hamburg | Doctorate Degree |
Statistiques
Internationale
| France | 3 |
| Allemagne | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Non-Durables | 5 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| DANONE | Consumer Non-Durables |
| L'ORÉAL | Consumer Non-Durables |
| CORBION N.V. | Consumer Non-Durables |
| YAKULT HONSHA CO.,LTD. | Consumer Non-Durables |
| Entreprise privées | 2 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
| MucoVax GmbH |
- Bourse
- Insiders
- Sven Thormahlen
- Expérience